Owner only: item control page
Kebir, Sied ; Schaub, Christina ; Junold, Nina ; Hattingen, Elke 
; Schäfer, Niklas ; Steinbach, Joachim P. ; Weyerbrock, Astrid ; Hau, Peter ; Goldbrunner, Roland ; Galldiks, Norbert ; Weller, Johannes ; Mack, Frederic ; Tzaridis, Theophilos ; Bähr, Oliver ; Seidel, Clemens ; Schlegel, Uwe ; Schmidt-Graf, Friederike ; Rohde, Veit ; Borchers, Christian ; Tabatabai, Ghazaleh ; Hänel, Mathias ; Sabel, Michael ; Gerlach, Rüdiger ; Krex, Dietmar ; Belka, Claus ; Vatter, Hartmut ; Proescholdt, Martin ; Glas, Martin ; Herrlinger, Ulrich
; Schäfer, Niklas ; Steinbach, Joachim P. ; Weyerbrock, Astrid ; Hau, Peter ; Goldbrunner, Roland ; Galldiks, Norbert ; Weller, Johannes ; Mack, Frederic ; Tzaridis, Theophilos ; Bähr, Oliver ; Seidel, Clemens ; Schlegel, Uwe ; Schmidt-Graf, Friederike ; Rohde, Veit ; Borchers, Christian ; Tabatabai, Ghazaleh ; Hänel, Mathias ; Sabel, Michael ; Gerlach, Rüdiger ; Krex, Dietmar ; Belka, Claus ; Vatter, Hartmut ; Proescholdt, Martin ; Glas, Martin ; Herrlinger, Ulrich Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial
Kebir, Sied, Schaub, Christina, Junold, Nina, Hattingen, Elke, Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Galldiks, Norbert , Weller, Johannes , Mack, Frederic, Tzaridis, Theophilos, Bähr, Oliver, Seidel, Clemens, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Borchers, Christian, Tabatabai, Ghazaleh , Hänel, Mathias, Sabel, Michael, Gerlach, Rüdiger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Glas, Martin and Herrlinger, Ulrich
(2019)
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
Journal of Neuro-Oncology 144 (3), pp. 501-509.
Date of publication of this fulltext: 03 Sep 2021 09:47
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal of Neuro-Oncology | ||||
| Publisher: | Springer | ||||
|---|---|---|---|---|---|
| Place of Publication: | NEW YORK | ||||
| Volume: | 144 | ||||
| Number of Issue or Book Chapter: | 3 | ||||
| Page Range: | pp. 501-509 | ||||
| Date | 2019 | ||||
| Institutions | Medicine > Lehrstuhl für Neurochirurgie Medicine > Lehrstuhl für Neurologie | ||||
| Identification Number |
| ||||
| Keywords | PREDICTIVE IMAGING BIOMARKER; ADC HISTOGRAM ANALYSIS; CEREBRAL BLOOD-VOLUME; RECURRENT GLIOBLASTOMA; PLUS IRINOTECAN; TEMOZOLOMIDE; PROGRESSION; EFFICACY; Bevacizumab; Irinotecan; Newly diagnosed MGMT-non-methylated glioblastoma; MRI; Predictive and prognostic implications | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 48280 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric